Voice your opinion on congressional bill S1218-118 and let lawmakers know your stance with UnPac!

Fair Prescription Drug Prices for Americans Act

This bill caps the price of drugs and biologics at the average price among certain countries.

Specifically, the retail list price of a drug or biologic in the United States may not exceed the average retail list price among Canada, France, Germany, Italy, Japan, and the United Kingdom. The Department of Health and Human Services (HHS) must calculate the average price in these countries based on data that is submitted by manufacturers directly to HHS and on publicly filed materials from manufacturers.

Manufacturers who violate the bill's price cap are subject to civil penalties.

Senate Actions

IntroReferral
Apr. 19 2023	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Library of Congress Actions

IntroReferral
Apr. 19 2023	Introduced in Senate

Senate bill S1218-118

Fair Prescription Drug Prices for Americans Act

Promote the cause!

Or use this QR code